Nephraegis Therapeutics

company

About

Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).

Details

Last Funding Type
Seed
Industries
Biopharma,Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2018
Operating Status
Active

Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Nephraegis Therapeutics has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 12, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 12, 2021 Seed 1 Xontogeny Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Nephraegis Therapeutics is funded by 1 investors. Xontogeny are the most recent investors.
Investor Name Lead Investor Funding Round
Xontogeny Yes Seed